BioCentury
ARTICLE | Company News

InVivo Therapeutics management update

September 16, 2013 7:00 AM UTC

InVivo Therapeutics Holdings Corp. (OTCBB:NVIV), Cambridge, Mass. Business: Neurology Resigned: Sean Moran as acting CFO; Interim CEO Michael Astrue will serve as principal financial officer until InV...